Join the Oncology Voice Network. Join for Free
How Competition Fuels Collaboration in Oncology

How Competition Fuels Collaboration in Oncology


Share This Article


Can rivalry actually unlock true collaboration in cancer drug development? In this episode of the Oncology Voice Network podcast, Dr. Kirk Shepard sits down with Tim Mikhelashvili, CEO and cofounder of Amadea Pharma and the mastermind behind the Medical Innovation Olympics. They challenge conventional wisdom, revealing how competition and recognition can strengthen, not sabotage, teamwork in oncology. Hear the inside story of the Medical Innovation Olympics—where leaders from rival companies present side-by-side, sparking bold ideas and even unexpected partnerships. Tim Mikhelashvili pulls back the curtain on why most collaboration barriers are about people, not science or technology. Discover practical, surprising strategies from the world of sports that help medical teams perform at Olympic levels day after day. Get the truth about bottlenecks that stifle innovation, how transparency and accountability change behaviors, and why measuring real contributions is the game-changer oncology needs. Listen now and join the movement reshaping how oncology leaders compete and win together.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
OVN Avatar Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Explore OVN